a month ago
DFTX
AnalystsJustin WalshJustin Walsh's Stock Forecasts
AnalystsJustin Walsh
Analyst Ranking
Top 19%
#1037 out of 5510 analysts
Average Return
+17.9%
Win Rate
37%18 out of 49
Risk vs Reward
Poor
Good
Justin Walsh's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Praxis Precision Medicines IncPRAX | +639.73% | $45.23 | $334.58 | 2025-09-18 - 2026-09-11 | Strong Buy |
Alto Neuroscience IncANRO | +354.13% | $3.75 | $17.03 | 2024-12-16 - 2025-12-15 | Strong Buy |
Harrow IncHROW | +261.36% | $5.90 | $21.32 | 2022-05-20 - 2023-05-19 | Strong Buy |
Perspective Therapeutics IncCATX | +254.25% | $2.52 | $8.92 | 2023-11-15 - 2024-11-14 | Strong Buy |
Definium Therapeutics IncDFTX | +177.39% | $14.02 | $38.89 | 2025-12-23 - 2026-09-11 | Strong Buy |
Justin Walsh Analyst Color
Get additional color on Justin Walsh's coverage of popular stocks
2 months ago
LNTH
3 months ago
DFTX
2 years ago
LNTH
2 years ago
LNTH
2 years ago
CATX
2 years ago
LNTH
Justin Walsh's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Seaport Therapeutics IncSPTX | 1 | Strong Buy | $32.00 | +37.10% | Initiates Coverage On | 19 days ago |
Definium Therapeutics IncDFTX | 3 | Strong Buy | $90.00 | +131.42% | Maintains | a month ago |
Ataibeckley IncATAI | 2 | Hold | N/A | N/A | Downgrades | 2 months ago |
Lantheus Holdings IncLNTH | 12 | Strong Buy | $129.00 | +28.68% | Maintains | 2 months ago |
Alto Neuroscience IncANRO | 2 | Strong Buy | $44.00 | +37.50% | Maintains | 5 months ago |
Neuroone Medical Technologies CorpNMTC | 1 | Strong Buy | $9.00 | +476.92% | Initiates Coverage On | 6 months ago |
Praxis Precision Medicines IncPRAX | 1 | Strong Buy | $83.00 | -75.19% | Initiates Coverage On | a year ago |
Y Mabs Therapeutics IncYMAB | 2 | Hold | N/A | N/A | Downgrades | a year ago |
Theratechnologies IncTHTX | 3 | Hold | N/A | N/A | Downgrades | a year ago |
Volitionrx LtdVNRX | 1 | Strong Buy | $60.00 | N/A | Initiates Coverage On | a year ago |
Biolinerx LtdBLRX | 3 | Strong Buy | $12.00 | N/A | Upgrades | a year ago |
Clene IncCLNN | 1 | Strong Buy | $30.00 | N/A | Initiates Coverage On | a year ago |
Monopar TherapeuticsMNPR | 1 | Hold | N/A | N/A | Downgrades | a year ago |
Serina Therapeutics IncSER | 1 | Strong Buy | $11.00 | N/A | Initiates Coverage On | 2 years ago |
Rapport Therapeutics IncRAPP | 1 | Strong Buy | $42.00 | N/A | Initiates Coverage On | 2 years ago |
Perspective Therapeutics IncCATX | 2 | Strong Buy | $22.00 | N/A | Maintains | 2 years ago |
Trisalus Life Sciences IncTLSI | 1 | Strong Buy | $16.00 | N/A | Initiates Coverage On | 2 years ago |
Achieve Life Sciences IncACHV | 1 | Strong Buy | $20.00 | N/A | Initiates Coverage On | 2 years ago |
Fusion Pharmaceuticals IncFUSN | 2 | Hold | N/A | N/A | Downgrades | 2 years ago |
Point Biopharma Global IncPNT | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Cytosorbents CorpCTSO | 3 | Strong Buy | $80.00 | N/A | Reinstates | 3 years ago |
Prime Medicine IncPRME | 1 | Strong Buy | $20.00 | N/A | Initiates Coverage On | 3 years ago |
Vor Biopharma IncVOR | 2 | Strong Buy | $360.00 | N/A | Initiates Coverage On | 3 years ago |
Viewray IncVRAYQ | 2 | Hold | $1.00 | N/A | Downgrades | 3 years ago |
Tff Pharmaceuticals IncTFFP | 1 | Strong Buy | $175.00 | N/A | Initiates Coverage On | 3 years ago |
Quantum Cyber NvQUCY | 1 | Strong Buy | $440.00 | N/A | Initiates Coverage On | 4 years ago |
Cerenome IncCNSY | 1 | Strong Buy | $1,875.00 | N/A | Initiates Coverage On | 4 years ago |
Harrow IncHROW | 1 | Strong Buy | $20.00 | N/A | Maintains | 4 years ago |
Curis IncCRIS | 2 | Strong Buy | $4,000.00 | N/A | Maintains | 4 years ago |
Compass Therapeutics IncCMPX | 1 | Strong Buy | $10.00 | N/A | Initiates Coverage On | 5 years ago |
Alpha Compute CorpALP | 1 | Strong Buy | $800.00 | N/A | Initiates Coverage On | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.